Complete Genome Sequences of Zika Virus Strains Used for the Formulation of CBER/FDA RNA Reference Reagents and Lot Release Panels for Nucleic Acid Technology Testing
- PMID: 29976606
- PMCID: PMC6033982
- DOI: 10.1128/genomeA.00572-18
Complete Genome Sequences of Zika Virus Strains Used for the Formulation of CBER/FDA RNA Reference Reagents and Lot Release Panels for Nucleic Acid Technology Testing
Abstract
We report here the complete genome sequences of two Zika virus strains (FSS13025 and PRVABC59) used for formulation of CBER/FDA RNA reference reagents and lot release panels for use with nucleic acid technology (NAT) testing.
References
-
- Besnard M, Lastère S, Teissier A, Cao-Lormeau V, Musso D. 2014. Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill 19:pii=20751 https://www.eurosurveillance.org/images/dynamic/EE/V19N13/art20751.pdf. - PubMed
-
- European Centre for Disease Prevention and Control. 2016. Rapid risk assessment. Zika virus disease epidemic: sixth update. European Centre for Disease Prevention and Control, Stockholm, Sweden.
-
- Pan American Health Organization. 2015. Epidemiological alert. Neurological syndrome, congenital malformations, and Zika virus infection. Implications for public health in the Americas. Pan American Health Organization, Washington, DC.
LinkOut - more resources
Full Text Sources
Other Literature Sources